Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (21)
Cancer Screening and Survivorship (6)
Cell Therapy (27)
Clinical Trials (19)
COVID-19 (7)
Gastrointestinal Cancer (13)
Genitourinary Cancer (11)
Gynecologic Oncology (12)
Head and Neck Cancer (12)
Hematologic Oncology (36)
Immunotherapy (32)
Neuro-Oncology (8)
Pediatric Hematology/Oncology (9)
Primary Care (10)
Radiation Oncology (11)
Skin Cancer (10)
Thoracic Cancer (16)
Young Adult Malignancies (2)

Types

News (142)

Showing 133 - 142 of 142 results

Previous| 1... 10 | 11 | 12 |Next

Roswell Park Reports Extended Survival Among Breast Cancer Survivors Who Exercise Regularly

Roswell Park Reports Extended Survival Among Breast Cancer Survivors Who Exercise Regularly

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Collaborative Effort Brings Investigational COVID-19 Treatment Approach to Western New York

Collaborative Effort Brings Investigational COVID-19 Treatment Approach to Western New York

Roswell Park Finds New Evidence That Inhaled Vitamin E Acetate Caused EVALI in Vapers

Roswell Park Finds New Evidence That Inhaled Vitamin E Acetate Caused EVALI in Vapers

Myeloma Trials Quick Guide

Myeloma Trials Quick Guide

New Center for Indigenous Cancer Research at Roswell Park Has Regional Focus, Global Reach

New Center for Indigenous Cancer Research at Roswell Park Has Regional Focus, Global Reach

Alternative Pain-Control Strategy Reduces Need for Opioids in Patients with Head and Neck Cancer

Alternative Pain-Control Strategy Reduces Need for Opioids in Patients with Head and Neck Cancer

Roswell Park Earns Distinction for Cellular Immunotherapy Through BlueCross BlueShield

Roswell Park Earns Distinction for Cellular Immunotherapy Through BlueCross BlueShield

Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM

Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Showing 133 - 142 of 142 results

Previous| 1... 10 | 11 | 12 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer